Reach of State-Mandated Insurance Coverage for Fertility Preservation in Patients With Cancer

Purpose Fertility preservation (FP) before cancer treatment effectively reduces iatrogenic infertility. Twenty-three states and the District of Columbia have passed insurance mandates for medically indicated FP coverage, but empiric data on population reach are lacking. We assessed the reach of California's mandate among young patients with cancer and sought to identify if social determinants of health (SDOH) are associated with mandate eligibility. Methods A retrospective cohort study was conducted of all female patients age 0-42 years and male patients age 0-49 years newly diagnosed with cancer at a National Cancer Institute–designated Comprehensive Cancer Center between 2021 and 2024. SDOH included sex, age, race, ethnicity, primary language, and Social Vulnerability Index (SVI). The primary outcome was eligibility for FP coverage under California's mandate. Secondary outcomes included insurer confirmation of FP benefits and time required for benefit verification. Results Of 903 patients, 18% were eligible for state-mandated FP benefits. Ineligibility was due to insurance by Medicaid (49%), ineligible commercial plans (37%), military-based plans (9%), federal-employee plans (2%), or being uninsured (3%). Non–English-speaking patients were 64% less likely to be eligible versus English-speaking patients (adjusted relative risk, 0.36 [95% CI, 0.17 to 0.75]) in adjusted analysis. Subgroup analyses showed that eligible patients differed significantly from ineligible Medicaid-insured patients by race, primary language, and SVI, but did not differ from ineligible commercially insured patients. Among patients with plans subject to the mandate, insurers inaccurately reported that they had no FP coverage 28% of the time. Benefit verification required a median of 45 minutes per patient (range, 9-350 minutes, interquartile range, 25-80). These secondary outcomes differed significantly by insurer ( P < .001). Conclusion California's mandate excludes most at-risk patients with cancer and perpetuates disparities in access. Future work in oncofertility health policy must consider mandate design and downstream implementation to eliminate barriers to care.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-11-20
DOI
https://doi.org/10.1200/jco-26-01296
Primary Topic
Reproductive Biology and Fertility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Reach of State-Mandated Insurance Coverage for Fertility Preservation in Patients With Cancer

An Zhang, Sally A.D. Romero, Nia Palmer, Hui-Chun Irene Su et al.
4 links
Journal of Clinical Oncology
Reproductive Biology and Fertility
article

Reach of State-Mandated Insurance Coverage for Fertility Preservation in Patients With Cancer

An Zhang, Sally A.D. Romero, Nia Palmer, Hui-Chun Irene Su, Kelly M. Chacón, Sara B. McMenamin, Helen Palomino, Bonnie N. Kaiser, Kristina Nguyen, Dunay Bach, Keri Tomechko, Lourdes Murcia, Ricardo E. Flores Ortega, Blanca Equihua
article en

Abstract

Purpose Fertility preservation (FP) before cancer treatment effectively reduces iatrogenic infertility. Twenty-three states and the District of Columbia have passed insurance mandates for medically indicated FP coverage, but empiric data on population reach are lacking. We assessed the reach of California's mandate among young patients with cancer and sought to identify if social determinants of health (SDOH) are associated with mandate eligibility. Methods A retrospective cohort study was conducted of all female patients age 0-42 years and male patients age 0-49 years newly diagnosed with cancer at a National Cancer Institute–designated Comprehensive Cancer Center between 2021 and 2024. SDOH included sex, age, race, ethnicity, primary language, and Social Vulnerability Index (SVI). The primary outcome was eligibility for FP coverage under California's mandate. Secondary outcomes included insurer confirmation of FP benefits and time required for benefit verification. Results Of 903 patients, 18% were eligible for state-mandated FP benefits. Ineligibility was due to insurance by Medicaid (49%), ineligible commercial plans (37%), military-based plans (9%), federal-employee plans (2%), or being uninsured (3%). Non–English-speaking patients were 64% less likely to be eligible versus English-speaking patients (adjusted relative risk, 0.36 [95% CI, 0.17 to 0.75]) in adjusted analysis. Subgroup analyses showed that eligible patients differed significantly from ineligible Medicaid-insured patients by race, primary language, and SVI, but did not differ from ineligible commercially insured patients. Among patients with plans subject to the mandate, insurers inaccurately reported that they had no FP coverage 28% of the time. Benefit verification required a median of 45 minutes per patient (range, 9-350 minutes, interquartile range, 25-80). These secondary outcomes differed significantly by insurer ( P < .001). Conclusion California's mandate excludes most at-risk patients with cancer and perpetuates disparities in access. Future work in oncofertility health policy must consider mandate design and downstream implementation to eliminate barriers to care.

Journal of Clinical Oncology
San Diego State University (US), Riverside University Health System - Medical Center (US), University of California San Diego (US), Cancer Resource Center of the Desert (US), Moores Cancer Center (US)
Good health and well-being, Reduced inequalities
Reproductive Biology and Fertility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon